Compare AdaptHealth Corp (AHCO) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AdaptHealth Corp vs Regeneron Pharmaceuticals Inc — how do they compare? AdaptHealth Corp trades at $5.66 (market cap $753.09M), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 109× AdaptHealth Corp's market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | REGN | |
|---|---|---|
Market Cap | $753.09M | $82.06B |
Sector | Health | Health |
52-Week High | $13.38 | $812.27 |
52-Week Low | $5.22 | $555.51 |
Enterprise Value | $2.77B | $76.77B |
Dividend Yield | — | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
